T1	Participants 17 57	patients with non-small cell lung cancer
T2	Participants 604 616	381 patients
T3	Participants 987 1098	median age 61 years, 69% male, 48% squamous cell, 93% WHO PS 0-1, 27% stage I, 38% stage II, and 34% stage III.
